David Navarro to Cytomegalovirus
This is a "connection" page, showing publications David Navarro has written about Cytomegalovirus.
Connection Strength
3.922
-
Cytomegalovirus DNAemia Burden and Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation: An Area Under a Curve-Based Investigational Approach. Clin Infect Dis. 2018 08 16; 67(5):805-807.
Score: 0.497
-
Monitoring of oral cytomegalovirus DNA shedding for the prediction of viral DNAemia in allogeneic hematopoietic stem cell transplant recipients. J Med Virol. 2018 08; 90(8):1375-1382.
Score: 0.487
-
Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested? Bone Marrow Transplant. 2018 06; 53(6):787-790.
Score: 0.487
-
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey. Transpl Infect Dis. 2017 Dec; 19(6).
Score: 0.470
-
Cytomegalovirus in Patients in the Intensive Care Unit. JAMA Intern Med. 2017 10 01; 177(10):1542-1543.
Score: 0.468
-
The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients. J Gen Virol. 2017 Oct; 98(10):2530-2542.
Score: 0.466
-
Assessing the risk of cytomegalovirus DNAaemia in allogeneic stem cell transplant recipients by monitoring oxidative-stress markers in plasma. J Gen Virol. 2017 Jul; 98(7):1855-1863.
Score: 0.461
-
Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2017 Aug; 19(4).
Score: 0.459
-
Going beyond serology for stratifying the risk of CMV infection in transplant recipients. Rev Med Virol. 2019 01; 29(1):e2017.
Score: 0.126